EMA opens consultation for Annex 15 GMP guidelines
By Catherine Eckford (European Pharmaceutical Review)
Lilly acquires CAR-T therapy biotech Orna Therapeutics for $2.4bn
By Catherine Eckford (European Pharmaceutical Review)
Roche’s fenebrutinib demonstrates decade-first benefit in multiple sclerosis
By Catherine Eckford (European Pharmaceutical Review)
Genentech gains rights to SanegeneBio’s RNAi pipeline for $1.5bn
By Catherine Eckford (European Pharmaceutical Review)
Accelerating consistent, stable cell line development with targeted integration
By Fei Chen (WuXi Biologics), Hang Zhou (WuXi Biologics), Tao…































